Jun 15, 2020
Global Thymus Cancer Market Insights by Cancer Type, Treatment, End-user and Region (2017-2025)
Jan 09, 2020
Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer
Sep 03, 2019
Macrophage Pharma Appoints Dr Søren Bregenholt as Chief Executive Officer
Jul 15, 2019
Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Generation mTORC1/2 Inhibitor
Feb 25, 2019
ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells
Feb 12, 2019
Iomab-B One of Four Late Breaking Oral Presentations to be Presented at the 2019 Transplantation & Cellular Therapy Annual Meeting
Nov 13, 2018
GammaDelta Therapeutics Announces Publication of New Data in Nature Immunology Describing the Independent Immune Function of Gamma Delta (gd) T Cell Receptors
Aug 20, 2018
NYU Langone's Blood & Marrow Transplant Program Expands Services
Jul 24, 2018
FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer
Jun 13, 2018
Autologous Lymph Node Transfer: New Hope for Combating Lymphedema
Jun 10, 2018
Cellenkos(TM), Inc. Announces FDA Clearance of Investigational New Drug Application for CK0801 for Bone Marrow Failure Syndromes
Apr 23, 2018
Shimadzu Corporation Releases New LIGHTVISION Near-infrared Fluorescence Imaging System
Apr 12, 2018
Three-Time Cancer Conqueror Who Completed Seven Marathons on Seven Continents After Relearning How to Walk Celebrates Fourteen-Year Anniversary of Bone Marrow Transplant
Mar 27, 2018
Feinstein Institute researcher defines a part of the body as an organ
Mar 27, 2018
Researchers Find New "Organ" Missed by Gold Standard Methods for Visualizing Anatomy and Disease
Mar 15, 2018
Vogue Magazine Features LPG endermologie® Technology For Body Sculpting Through Massage
Feb 13, 2018
GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia
Jan 04, 2018
Eiger BioPharmaceuticals Completes Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients